Unity Biotechnology (NASDAQ:UBX – Get Rating) had its target price reduced by Wedbush from $35.00 to $5.00 in a report issued on Tuesday, The Fly reports. They currently have an outperform rating on the stock. Wedbush also issued estimates for Unity Biotechnology’s FY2026 earnings at ($12.94) EPS and FY2027 earnings at ($15.07) EPS. Several other […]
Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Investment analysts at Wedbush decreased their FY2026 EPS estimates for Unity Biotechnology in a research note issued to investors on Tuesday, March 28th. Wedbush analyst A. Argyrides now anticipates that the company will earn ($12.94) per share for the year, down from their prior estimate of ($12.04). […]
Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price objective reduced by Mizuho from $12.00 to $6.00 in a research report released on Tuesday morning, The Fly reports. They currently have a buy rating on the stock. A number of other equities analysts also recently issued reports on the company. HC Wainwright reissued a buy […]
Unity Biotechnology (NASDAQ:UBX – Get Rating) had its target price decreased by Mizuho from $12.00 to $6.00 in a report published on Tuesday morning, The Fly reports. Mizuho currently has a buy rating on the stock. UBX has been the topic of a number of other reports. Wedbush reiterated an outperform rating and set a […]
Unity Biotechnology (NASDAQ:UBX – Get Rating)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a note issued to investors on Tuesday, Benzinga reports. They presently have a $10.00 target price on the stock. HC Wainwright’s price objective would indicate a potential upside of 488.24% from the stock’s current price. Other […]